Poland Issues First Permit for Medical Cannabis Cultivation

The Chief Pharmaceutical Inspectorate has issued the first permit in Poland for the cultivation of medical cannabis. This groundbreaking event opens a new chapter in the production of cannabis for medical purposes. It seems that patients in Poland will finally have access to medical cannabis from local cultivation.

The Industrial Biotechnology Institute of Agriculture and Food Industry, led by Prof. Wacław Dąbrowski, together with the team from Cannabisland (Cultivation Department) and Plantalux (LED lamp manufacturer), have led this groundbreaking decision.

Despite complex laws, they have managed to obtain a permit for the cultivation of medical cannabis. The facility located in the Lublin Voivodeship in Konopnica has passed all the required safety procedures, in accordance with the law of March 24, 2022, which allows for the cultivation of non-fiber hemp for the production of pharmaceutical raw material, by Institutes supervised by the Minister of Agriculture.

For more news like this, along with all the latest in legalization, research, and lifestyle, download our free cannabis news app.

Implications for the Industry and Poland

This proves that the production of medical cannabis is possible under Polish legal and technological conditions. It’s a significant step for patients who will be able to use cannabis grown in Poland. This could mean that the price of cannabis in Polish pharmacies will be lower than before, as local cultivation will allow bypassing intermediaries who have so far imposed their margin.

The Institute, along with the Lachowski brothers (Rafał Lachowski and Jakub Lachowski), demonstrates that determination and modern technologies can overcome bureaucratic barriers. This is a historic moment for Poland, showing progress and determination.

The issuance of the first permit for the cultivation of medical cannabis in Poland is a significant step forward. It not only affects the development of the cannabis industry but also opens doors to new opportunities, such as the export of local raw material to other countries. More information about this groundbreaking event will be provided soon, when we receive detailed information about the people involved in the project.

First Polish Indoor Farm for Medical Cannabis Cultivation

In December 2023, the Chief Pharmaceutical Inspectorate gave the green light for this innovative initiative. Four months earlier, CannabisLand revealed on LinkedIn that the Industrial Biotechnology Institute of Agriculture and Food Industry named after Prof. Wacław Dąbrowski had inaugurated the first phase of the indoor farm in Konopnica, Lublin Voivodeship.

In Konopnica, the first cultivation of medical cannabis in Poland will take place. The Institute, under the leadership of Prof. Wacław Dąbrowski, successfully conducted the first phase of launching a modern indoor farm. This historic step began on March 24, 2022, when the amendment to the law allowing the cultivation of non-fiber hemp for the production of pharmaceutical raw material, by Institutes supervised by the Minister of Agriculture, came into force.

“Every story has its beginning. The beginning of our joint story starts today. In Konopnica (Lublin Voivodeship), the Industrial Biotechnology Institute of Agriculture and Food Industry named after Prof. Wacław Dąbrowski has successfully conducted the first phase of launching an indoor farm that will cultivate medical cannabis in Poland. The second phase of the project is underway and will be completed later this year. The Institute has been preparing for this day since March 24, 2022, when the amendment to the law came into force. Cannabisland and the Lachowski brothers (Rafał and Jakub) are key partners in this endeavor. More information coming soon,” – as read on the LinkedIn profile of CannabisLand.

Cannabisland and the Lachowski brothers (Rafał and Jakub) are key partners in this endeavor. Their support and commitment are invaluable in the process of creating new opportunities for the Polish cannabis industry. CannabisLand is a large cultivation facility with experience in the production of fiber cannabis. The Lachowski brothers own Plantalux, a company that specializes in LED lighting for cannabis cultivation. Their lamps are already used in many countries for the production of medical cannabis. The Institute, with their help, shows that despite complex laws, the cultivation of medical cannabis in Poland is possible and can meet international standards.

The Role of Partners in Advancing the Cannabis Industry

The collaboration with Cannabisland and the Lachowski brothers highlights the importance of partnerships in overcoming challenges and advancing the industry. CannabisLand’s extensive experience in cannabis cultivation and Plantalux’s expertise in LED lighting are crucial in setting a high standard for medical cannabis production in Poland. Their involvement underscores the role of innovative technologies and committed stakeholders in the successful cultivation of medical cannabis under stringent legal and safety requirements.

This collaboration not only sets a precedent for medical cannabis cultivation in Poland but also paves the way for future developments in the industry. The combined efforts of research institutes and private sector partners are essential in ensuring the growth and sustainability of the cannabis industry in Poland and potentially in international markets.

A Look Forward: Next Steps and Future Prospects

As the project progresses, further details about the phases of cultivation, technological innovations, and the potential impact on the medical community and patients are eagerly anticipated. This initiative is a beacon of hope for patients in need of medical cannabis and represents a significant advancement in the medical and agricultural sectors in Poland. The successful cultivation and potential export of medical cannabis could position Poland as a key player in the global cannabis market, offering new economic opportunities and contributing to medical research and treatments.

—

(Featured image by CRYSTALWEED Cannabis via Unsplash)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Fakty Konopne, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.